A detailed history of Abel Hall, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Abel Hall, LLC holds 4,483 shares of AZN stock, worth $294,219. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,483
Previous 4,613 2.82%
Holding current value
$294,219
Previous $360 Million 2.92%
% of portfolio
0.23%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$76.67 - $87.62 $9,967 - $11,390
-130 Reduced 2.82%
4,483 $349 Million
Q2 2024

Jul 25, 2024

BUY
$66.81 - $80.83 $51,911 - $62,804
777 Added 20.26%
4,613 $360 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $9,337 - $10,644
153 Added 4.15%
3,836 $260 Million
Q4 2023

Feb 28, 2024

BUY
$61.89 - $69.28 $227,940 - $255,158
3,683 New
3,683 $248 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.